Epigenetics of cancer-associated muscle catabolism

Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia

(2016) Rulin Sun et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Muscle cell identity requires Pax7-mediated lineage-specific DNA demethylation

(2016) Elvira Carrió et al.   BMC BIOLOGY

CCAAT/enhancer binding protein beta protects muscle satellite cells from apoptosis after injury and in cancer cachexia

(2016) F Marchildon et al.   Cell Death & Disease

Concise Review: Epigenetic Regulation of Myogenesis in Health and Disease

(2016) Marie-Claude Sincennes et al.   Stem Cells Translational Medicine

Regulation of skeletal muscle development and homeostasis by gene imprinting, histone acetylation and microRNA

(2015) Viviana Moresi et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

The NAD+-Dependent SIRT1 Deacetylase Translates a Metabolic Switch into Regulatory Epigenetics in Skeletal Muscle Stem Cells

(2015) James G. Ryall et al.   Cell Stem Cell

MiR-206, a Key Modulator of Skeletal Muscle Development and Disease

(2015) Guoda Ma et al.   International Journal of Biological Sciences

Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia

(2015) Yu-Chou Tseng et al.   JNCI-Journal of the National Cancer Institute

Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia

(2015) Yu-Chou Tseng et al.   JNCI-Journal of the National Cancer Institute

SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-binding-dependent manner

(2014) Lance M. Bollinger et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Dystrophic muscle environment induces changes in cell plasticity

(2014) H. Faralli et al.   GENES & DEVELOPMENT

NF-κB–mediated Pax7 dysregulation in the muscle microenvironment promotes cancer cachexia

(2013) Wei A. He et al.   JOURNAL OF CLINICAL INVESTIGATION

Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index

(2013) Lisa Martin et al.   JOURNAL OF CLINICAL ONCOLOGY

Smad3 Induces Atrogin-1, Inhibits mTOR and Protein Synthesis, and Promotes Muscle Atrophy In Vivo

(2013) Craig A. Goodman et al.   MOLECULAR ENDOCRINOLOGY

Multiple muscle wasting-related transcription factors are acetylated in dexamethasone-treated muscle cells

(2012) Wei Chamberlain et al.   Biochemistry and Cell Biology

Myostatin: more than just a regulator of muscle mass

(2012) Josep M. Argilés et al.   DRUG DISCOVERY TODAY

Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells

(2012) Huitao Fan et al.   Epigenetics

microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice

(2012) Ning Liu et al.   JOURNAL OF CLINICAL INVESTIGATION

Acetylation and deacetylation—novel factors in muscle wasting

(2012) Nima Alamdari et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

C/EBPβ regulates dexamethasone-induced muscle cell atrophy and expression of atrogin-1 and MuRF1

(2011) Patricia Gonnella et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

The role of myostatin in muscle wasting: an overview

(2011) Yulia Elkina et al.   Journal of Cachexia Sarcopenia and Muscle

The TWEAK–Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice

(2010) Ashwani Mittal et al.   JOURNAL OF CELL BIOLOGY

TNF Inhibits Notch-1 in Skeletal Muscle Cells by Ezh2 and DNA Methylation Mediated Repression: Implications in Duchenne Muscular Dystrophy

(2010) Swarnali Acharyya et al.   PLoS One

Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size

(2009) Anne Ulrike Trendelenburg et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Smad2 and 3 transcription factors control muscle mass in adulthood

(2009) Roberta Sartori et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation

(2009) Shenhav Cohen et al.   JOURNAL OF CELL BIOLOGY

Epigenetic drugs in the treatment of skeletal muscle atrophy

(2008) Valentina Guasconi et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

MAFbx/Atrogin-1 Controls the Activity of the Initiation Factor eIF3-f in Skeletal Muscle Atrophy by Targeting Multiple C-terminal Lysines

(2008) Alfredo Csibi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Protein Kinase D1 Stimulates MEF2 Activity in Skeletal Muscle and Enhances Muscle Performance

(2008) M.-S. Kim et al.   MOLECULAR AND CELLULAR BIOLOGY